Molecular Templates, Inc.
MTEM
MTEM was delisted on the 24th of December, 2024.
29 hedge funds and large institutions have $26.9M invested in Molecular Templates, Inc. in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 16 closing their positions.
360% more capital invested
Capital invested by funds: $5.84M → $26.9M (+$21M)
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
22% less funds holding
Funds holding: 37 → 29 (-8)
44% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$5.84M |
| 2 |
PA
Perceptive Advisors
New York
|
+$4.17M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$4.17M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$903K |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$417K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$354K |
| 2 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$79K |
| 3 |
AFS
Amtrust Financial Services
New York
|
-$39K |
| 4 |
JIR
James Investment Research
Alpha,
Ohio
|
-$32K |
| 5 |
Bank of New York Mellon
New York
|
-$30K |
MTEM Hedge Fund Activity: Q3 2017 in Review
29 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Molecular Templates, Inc. (MTEM) for Q3 2017, worth a combined $26.9M — up 360% from $5.84M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of MTEM and 9 opened new positions — a net loss of 7 holders — while 5 trimmed existing stakes and 7 added.
The largest buyer was Caxton Corporation, opening a new position worth an estimated $5.84M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $354K sold.
- 29 institutional investors held Molecular Templates, Inc. (MTEM) as of Q3 2017, down from 37 in Q2 2017.
- Funds reported $26.9M of Molecular Templates, Inc. stock for Q3 2017, up 360% quarter-over-quarter.
- 9 funds opened new Molecular Templates, Inc. positions in Q3 2017 and 16 closed out, a net change of -7 holders.
- The largest Molecular Templates, Inc. buyer in Q3 2017 was Caxton Corporation, an estimated $5.84M added.
- The largest Molecular Templates, Inc. seller in Q3 2017 was Cormorant Asset Management, an estimated $354K sold.
Based on aggregated 13F filings for Q3 2017.